Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells
Polarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus
Harnessing dendritic cells to generate cancer vaccines
Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers
Brain tumor immunotherapy with type-1 polarizing strategies
Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo
Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens
Therapeutic potential of dendritic cell vaccines in sarcoma of the extremities
Serum and tissue selenium levels in gastric cancer patients and correlation with CEA
Killer dendritic cells and their potential for cancer immunotherapy
Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer
Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice
Cryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy
Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma
Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10
Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer
Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase
Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma
Generation of a dendritic cell-based vaccine in chronic lymphocytic leukaemia using CliniMACS platform for large-scale production